分类： health

In an ongoing public health crisis centered in the northeastern Democratic Republic of the Congo, a rare strain of Ebola has sparked an outbreak that the World Health Organization has now designated a Public Health Emergency of International Concern (PHEIC), with fatalities topping 100 and cases already spreading into neighboring Uganda. What follows is a comprehensive chronological breakdown of how the under-recognized crisis unfolded, marked by early challenges in identifying the unusual pathogen behind the spread of disease.

Between April 24 and 27, the first suspected case of the mysterious illness – a local health worker – fell ill and died in Bunia, the capital of Congo’s Ituri Province. According to Congo’s health minister, the worker’s body was subsequently transported to the nearby mining hub of Mongbwalu. While Congolese officials cite April 24 as the date of death, the Africa Centers for Disease Control and Prevention (Africa CDC) records the death occurring on April 27, following the onset of severe hemorrhagic symptoms characteristic of filovirus infections like Ebola.

On April 28, the Africa CDC confirmed that a close contact of the initial suspected victim had also died after developing matching disease symptoms. Just two days later, on April 30, on-site testing of patient samples in Bunia returned negative results for Zaire ebolavirus – the strain responsible for nearly all previous large Ebola outbreaks in Congo. The WHO notes that three Ebola species are known to trigger major outbreaks: Zaire, Sudan, and the far less common Bundibugyo virus. It would take a full two additional weeks for public health authorities to confirm that the rarer Bundibugyo strain was the actual cause of the outbreak.

By May 5, the WHO was formally notified of a “high-mortality” outbreak of unknown origin in Mongbwalu, with multiple health workers already counted among the deceased. Local preliminary reports placed the death toll at roughly 50 by this point. Congolese health officials later noted that the movement of the first victim’s contagious remains to Mongbwalu likely sparked the local transmission chain there, as bodies of Ebola victims carry extremely high infection risk.

On May 11, a 59-year-old Congolese man with Ebola-typical symptoms of fever and body aches checked into a hospital in Kampala, Uganda’s capital, located roughly 434 miles from Ituri Province. Ugandan health authorities confirmed he had crossed the border from Congo to seek care. A WHO rapid response team deployed to investigate the expanding outbreak in Mongbwalu and the nearby Rwampara health zone on May 13, as transmission continued to accelerate. The following day, 13 blood samples from suspected Ebola cases in Rwampara were sent for official analysis at a national laboratory in Kinshasa, Congo’s capital. That same day, the cross-border patient from Congo died in the Kampala hospital, and his remains were returned to Congo for burial.

May 15 marked a turning point in the crisis: laboratory analysis from Kinshasa confirmed the presence of Bundibugyo virus in eight of the 13 Rwampara samples. Posthumous testing of the Ugandan patient’s sample also returned positive for the rare strain, for which no licensed vaccine or specific antiviral treatment currently exists. The Congolese Ministry of Health officially declared an Ebola outbreak, with the Africa CDC reporting 246 suspected cases and 65 fatalities. Within days, those numbers jumped to more than 300 suspected cases and over 100 confirmed deaths. Ugandan officials confirmed their country’s cases were limited to two people, both of whom had entered Uganda from Congo. This outbreak marks the 17th major Ebola event in Congo since the virus was first discovered in the country in 1976.

On May 17, the WHO formally designated the cross-border outbreak in Congo and Uganda a PHEIC, the United Nations health agency’s highest level of public health alert. The WHO emphasized that the outbreak does not meet the criteria for a pandemic classification like that applied to COVID-19, and explicitly advised against countries closing their borders to Congo or Uganda. Even so, the agency urged all nations sharing a land border with the two affected countries to immediately strengthen routine disease surveillance and ensure frontline health workers receive specialized training to identify, triage and manage Ebola cases.

The following day, Congolese health officials confirmed that an American doctor working in Bunia had tested positive for the virus. Dr. Jean-Jacques Muyembe, medical director of Congo’s National Institute of Bio-Medical Research, confirmed the case was counted among the infections in Bunia, where the doctor had been treating patients at a local hospital, according to his employing organization.

This reporting was a collaborative effort by Associated Press writers based across the African continent: Monika Pronczuk in Dakar, Senegal, Evelyne Musambi in Nairobi, Kenya, and Rodney Muhumuza in Kampala, Uganda.

The World Health Organization (WHO) has formally designated an ongoing Ebola outbreak in the eastern region of the Democratic Republic of Congo (DRC) as a Public Health Emergency of International Concern (PHEIC), marking a major escalation of global response to a dangerous and uniquely challenging public health crisis.

Unlike more common Ebola variants that global health systems have experience addressing, this outbreak is driven by the Bundibugyo strain – an extremely rare subtype that has not triggered a major outbreak in more than 10 years. Only two previous Bundibugyo outbreaks have ever been recorded, with the virus claiming the lives of roughly one-third of all confirmed cases in those events. This rarity has created multiple layers of barriers to containment and treatment: standard initial Ebola diagnostic tests are calibrated to detect more common strains, leading to initial false negatives that delayed detection, and no officially approved vaccine or targeted antiviral treatment exists for this specific variant. While experimental vaccines are currently in development, researchers note that existing vaccines for the Zaire Ebola strain may offer partial cross-protection, though this has not been formally confirmed for widespread use.

Compounding these biological challenges is the outbreak’s location in an unstable conflict zone. Over a quarter of a million people have been displaced from their homes in the affected Ituri province, and porous, poorly monitored borders with neighboring countries have created constant risk of cross-border spread. The outbreak was not detected early after its initial emergence: the first documented case was a nurse who first developed symptoms on April 24, meaning the virus circulated undetected for multiple weeks before authorities were alerted. That nurse later died in Bunia, Ituri’s capital, and her body was transported back to Mongwalu – one of two gold-mining towns that have recorded the majority of confirmed cases. Congolese Health Minister Samuel Roger Kamba explained that widespread community transmission accelerated after the nurse’s funeral, where dozens of people were exposed to the infected body during traditional mourning practices. This mirrors patterns seen in past Ebola outbreaks across Africa, where funeral customs have repeatedly fueled spread.

Delayed reporting also stemmed from widespread misinformation in affected communities: many residents initially attributed the mysterious illness to witchcraft or a supernatural curse, leading sick people to seek care from traditional healers and prayer centers instead of formal medical facilities. This allowed transmission to continue uninterrupted for weeks. As of current reports, cases have been confirmed across three Ituri locations (Mongwalu, Rwampara, and Bunia) as well as Goma – the largest city in eastern DRC, home to 850,000 people and currently under the control of AFC-M23 rebel forces. The Goma case involves a woman who traveled to the city after her husband died of Ebola in Bunia. Alarmingly, two Congolese travelers who entered Uganda from the DRC have already died of Ebola in Kampala, Uganda’s capital, marking the first cross-border fatalities linked to the outbreak.

Contrary to widespread public speculation, WHO officials stress that this PHEIC declaration does not signal an impending COVID-19-style global pandemic. The overall risk of Ebola spread outside of East Africa remains categorized as minimal, with the greatest danger concentrated in the Great Lakes region of central Africa. Still, global health bodies are sounding the alarm about significant regional spread risks. The Africa Centres for Disease Control and Prevention (Africa CDC) has highlighted high risk of transmission to neighboring Uganda, Rwanda, and South Sudan, and is coordinating with officials from all four countries to strengthen cross-border surveillance and response capacity.

Neighboring nations have already implemented urgent precautionary measures. Rwanda, which shares a border with Goma, has ramped up entry screening for all travelers coming from the DRC, and has restricted entry for non-resident Congolese nationals coming from affected areas. In Uganda, President Yoweri Museveni has postponed the annual Martyrs’ Day pilgrimage – a major Christian event that draws thousands of Congolese visitors each year – to prevent large-scale gathering that could fuel transmission.

On the ground in the DRC, multiple response efforts are underway, but political fragmentation threatens to slow progress. The Congolese national government has deployed specialized health teams equipped with personal protective equipment to Bunia, and has launched a public awareness campaign alongside a toll-free hotline (151) for residents to report suspected symptoms. Public health officials have issued core guidance for residents: seek immediate medical care at the first sign of symptoms, avoid contact with bodies of people who died with suspected Ebola or dead wild animals, avoid eating raw or undercooked meat, and maintain physical distancing in public spaces. The WHO and medical humanitarian organization Médecins Sans Frontières (MSF) have also deployed personnel and resources to set up dedicated Ebola treatment centers and coordinate the overall response. In Goma, AFC-M23 rebel officials say they have activated their own response mechanisms in partnership with local health facilities to contain spread, but political tensions mean the Congolese national government is unlikely to collaborate with the rebel administration, creating a critical coordination gap that could hinder containment efforts.

Africa CDC Director Dr. Jean Kaseya says current public outreach efforts are focused on addressing the key risk factors that have driven spread so far, including educating communities on safe funeral practices, universal basic hygiene, and proper sanitation, as well as ensuring frontline health workers have access to adequate protective equipment to avoid infection while caring for patients.

A new, lethal Ebola outbreak spanning the Democratic Republic of Congo and Uganda has laid bare the growing vulnerability of African health systems, as plummeting international donor assistance forces the continent to confront a long-deferred reckoning: ending decades of dependency on foreign aid for public health emergency response.

According to the Africa Centers for Disease Control and Prevention (Africa CDC), the continent is grappling with an unprecedented health financing crisis. Official development assistance for health has been cut in half over just four years, plummeting from roughly $26 billion in 2021 to a projected $13 billion in 2025. Wealthy nations have redirected global health resources to prioritize geopolitical conflicts and domestic economic pressures, with sweeping cuts implemented during the Trump administration worsening the funding shortfall. The shrinking budget crisis arrives as Africa’s population has surpassed 1.5 billion and disease outbreaks are surging: the Africa CDC recorded a jump from 153 public health emergencies across the continent in 2022 to 242 in 2024, ranging from mpox and cholera to this latest Ebola strain, which has no approved vaccines or targeted treatments.

For decades, African governments signed pledges promising to increase domestic investment in public health, but few have followed through on those commitments. In the 2001 Abuja Declaration, 54 African nations committed to allocate a minimum of 15% of their national budgets to the health sector. Today, only three countries — Rwanda, Botswana, and Cape Verde — are on track to meet that target. Dr. Jean Kaseya, director-general of the Africa CDC, framed the funding gap as a threat as dangerous as any emerging pathogen, noting that “every time we have an outbreak, many countries start to ask for partners because they don’t have in their budgets funding to respond, even to prepare for these outbreaks.”

Dr. Alex Ajangba, a health financing expert and co-editor of the *African Journal of Health Economics, Systems and Policy*, explained that prior commitments to self-reliance remained theoretical as long as donor funding was available. “But now that cushion is gone,” he said, adding that the current drop in foreign assistance is not a temporary dip, but a permanent shift.

Against this backdrop, the concept of “health sovereignty” has moved to the center of continental policy, with African governments accelerating efforts to build self-sufficient health systems that rely far less on external aid. Recent initiatives, including Ghana’s September 2024 Accra Reset and the continent-wide African Health Security and Sovereignty Agenda adopted by leaders in February 2025, aim to strengthen long-term public health resilience. Proposed domestic solutions include new targeted taxes on tobacco, alcohol, and sugary beverages to generate health revenue, pooled bulk procurement of medicines to cut costs, expanding local pharmaceutical and vaccine manufacturing, and eliminating systemic inefficiencies that drain limited budgets.

Currently, Africa imports more than 90% of its critical health commodities, including vaccines and prescription drugs. The Africa CDC has set an ambitious target to produce 60% of the continent’s vaccines domestically by 2040. Still, experts warn that health sovereignty risks becoming little more than a empty policy slogan without meaningful structural and financial reform.

A key barrier to expanding domestic health investment is the paradox of Africa’s natural resource wealth: the continent holds roughly 30% of the world’s total mineral reserves, including critical minerals essential for global technology and renewable energy development, but most of the economic value of these resources never reaches national governments or public budgets. Opaque and weak contracting, massive illicit financial flows, crippling national debt burdens, and the export of raw minerals with limited local value processing drain hundreds of billions of dollars from African economies annually. The United Nations Economic Commission for Africa estimates the continent loses roughly $40 billion each year to illicit financial flows alone in the extractive sector.

To bridge the funding gap, global health bodies and African governments are increasingly turning to co-financing models, which require recipient nations to contribute a growing share of health funding alongside donor contributions. Gavi, the global vaccine alliance, reports that lower-income African nations contributed a record $302 million toward domestic vaccine purchases in 2025, and have contributed roughly $1 billion total over the past five years. “This creates predictability,” Gavi chief executive Sania Nishtar told the Associated Press. “Reliance on aid for basic services does not.”

But the shift toward new financing models has become contentious, particularly as the Trump administration has made co-financing a non-negotiable condition for “America First” health agreements with nearly two dozen African nations. The deals restructure U.S. aid to require countries to increase domestic health spending within set deadlines, or lose all U.S. support entirely. Some nations have rejected the agreements outright, pushing back against U.S. demands for access to domestic health data with no guarantees that African nations will share in any commercial benefits derived from that data. Other critics have condemned proposals that would swap health aid commitments for access to African natural resources.

While most African leaders agree that long-term self-sufficiency is a necessary goal, critics argue that many of the U.S. conditions place unfair, unrealistic pressure on economies already strained by debt and underdevelopment. “They are being set up to fail,” said Asia Russell, executive director of global health advocacy group Health GAP. “When an administration says, ‘If you don’t hit these numbers, you’re not going to get resources anymore,’ that is extremely serious.”

Mounting national debt burdens already make dramatic increases in domestic health spending nearly impossible for many nations. Africa’s total sovereign debt has surged to roughly $1.2 trillion, according to the African Export-Import Bank, forcing governments to make devastating trade-offs between public health and debt repayment. For roughly 40% of African countries, annual debt servicing costs exceed total national health spending. The United Nations reports that debt repayment consumes an average of 19% of total government revenue across sub-Saharan Africa. Jen Kates, senior vice president of global health policy nonprofit KFF, noted that “at the end of the day, it’s going to be people who live in those countries who will feel the effects” of underfunded health systems. The Associated Press receives financial support from the Gates Foundation for coverage of global health and development in Africa, and maintains full editorial control over all content.

DAKAR, Senegal – As a rare and deadly Ebola outbreak continues its spread across the eastern Democratic Republic of the Congo and spill over into neighboring Uganda, global and national health authorities have ramped up emergency responses, marking one of the most pressing public health crises in Africa this year. During an official visit to the Ebola-impacted Ituri region Sunday evening, Congolese Health Minister Samuel Roger Kamba announced the launch of three new dedicated Ebola treatment centers to expand strained care capacity in the hard-hit area. Standing in Bunia, Ituri’s provincial capital and largest urban center, Kamba acknowledged that existing local healthcare facilities are already overwhelmed by a surge of patients showing Ebola symptoms, but emphasized that the new facilities will boost the country’s ability to care for infected people and slow transmission. The World Health Organization had formally designated the outbreak a Public Health Emergency of International Concern (PHEIC) – the WHO’s highest level of global public health alert – earlier the same day, following weeks of rising case counts. As of the announcement, officials have recorded more than 300 suspected Ebola cases, with 88 confirmed fatalities in the DRC and two additional deaths in Uganda, where the virus has crossed the shared border. While the epicenter of the outbreak remains Ituri, suspected cases have already been documented as far as Kinshasa, the DRC’s national capital, and Goma, the largest city in the country’s eastern region, raising alarms about potential wider spread across Central Africa. In a separate post to the social platform X Sunday, the WHO Regional Office for Africa confirmed that a joint 35-member expert team from the global health body and the Congolese Ministry of Health has already deployed to Bunia, carrying 7 tons of critical emergency medical supplies and protective equipment to support response efforts. Ebola is a highly contagious viral pathogen that spreads through direct contact with infected bodily fluids including blood, vomit, and semen. While the disease is relatively rare, it causes severe, often fatal organ damage and bleeding in a majority of untreated cases. What makes the current outbreak particularly alarming for public health experts is that it is caused by the Bundibugyo virus, a rare Ebola variant that was only confirmed as the source of this outbreak this past Friday. No officially approved vaccines or targeted therapeutics currently exist for this specific strain, creating a critical gap in response capacity. Prior to 2024, the Bundibugyo variant has only been detected two other times in recorded history: first in Uganda’s Bundibugyo District during a 2007–2008 outbreak that sickened 149 people and killed 37, and again in a 2012 outbreak in the DRC’s Isiro region that recorded 57 cases and 29 deaths. Speaking to Sky News Sunday, Jean Kaseya, Director-General of the Africa Centres for Disease Control and Prevention, acknowledged the urgent gaps in the global response, saying, “Currently I’m on panic mode because people are dying, I don’t have medicines, I don’t have vaccine to support countries.” Kaseya added that he has convened an emergency meeting of all global public health and aid partners to advance access to experimental candidate vaccines and therapeutics, with the goal of rolling out limited supplies to impacted areas in the coming weeks. The WHO’s PHEIC designation is only triggered when an outbreak meets three strict criteria: it poses a serious enough threat to global health to require coordinated action, it carries a significant risk of international spread across borders, and it demands a unified, cross-country response. Global health leaders hope the declaration will accelerate funding commitments from donor nations and spur rapid action from pharmaceutical partners to make experimental treatments available to frontline teams. With more than 20 previous Ebola outbreaks recorded across the DRC and Uganda over the past half century, health authorities have well-established protocols for containing viral spread, but the lack of targeted tools for the rare Bundibugyo variant has created an unprecedented challenge for the current response.